DAS-MG, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis (NCT04226170) | DAS-MG, Inc | 2023-11-08 |
Track DAS-MG, Inc automatically
Every clearance here is in the API, with alerts when new ones post.